{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:08:37Z","timestamp":1750392517912,"version":"3.41.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126983","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:59:57Z","timestamp":1741460397000},"page":"126983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype"],"prefix":"10.1016","volume":"54","author":[{"given":"Zahrasadat","family":"Navaeiseddighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseem","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Shafat","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126983_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2025.126983_bb0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126983_bb0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126983_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jinf.2020.06.028","article-title":"Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: a systematic review of prevalence and individual participant data meta-analysis of risk factors","volume":"81","author":"Smith","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.126983_bb0025","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3389\/fimmu.2018.02275","article-title":"Role of inflammatory risk factors in the pathogenesis of Streptococcus pneumoniae","volume":"9","author":"Sohail","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.126983_bb0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126983_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1198545","article-title":"Rapid pneumococcal evolution in response to clinical interventions","volume":"331","author":"Croucher","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.126983_bb0040","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/INF.0b013e31828d9acc","article-title":"Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York","volume":"32","author":"Casey","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.126983_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206622","article-title":"Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene","volume":"13","author":"Manna","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.126983_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cmi.2019.10.034","article-title":"Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain","volume":"26","author":"Gonzalez-Diaz","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.126983_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fmicb.2020.00309","article-title":"Clinical relevance and molecular pathogenesis of the emerging serotypes 22F and 33F of Streptococcus pneumoniae in Spain","volume":"11","author":"Sempere","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.126983_bb0060","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1016\/j.vaccine.2018.08.017","article-title":"Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection","volume":"36","author":"Khan","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126983_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bit.26083","article-title":"Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates","volume":"114","author":"Zhang","year":"2017","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2025.126983_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.vaccine.2020.11.075","article-title":"Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models","volume":"39","author":"Schmit","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126983_bb0075","first-page":"85","article-title":"Protection against Streptococcus pneumoniae invasive pathogenesis by a protein-based vaccine is achieved by suppression of nasopharyngeal bacterial density during influenza a virus coinfection","author":"Khan","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126983_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/infdis\/jiz193","article-title":"Double-edged role of interleukin 17A in Streptococcus pneumoniae pathogenesis during influenza virus coinfection","volume":"220","author":"Ambigapathy","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126983_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03615-22","article-title":"Impact of COVID-19 nonpharmaceutical interventions on pneumococcal carriage prevalence and density in Vietnam","volume":"11","author":"Nation","year":"2023","journal-title":"Microbiol Spectr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:20:56Z","timestamp":1750342856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":17,"alternative-id":["S0264410X25002804"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126983","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126983"}}